Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Eosinophilic angiocentric fibrosis in paediatric IgG4-related disease.

Created on 07 Oct 2026

Authors

Rupal Prasad, Parag Vijayvergia, Mahima Khatkar, Puneet Kumar, Bandana Mehrotra

Published in

BMJ case reports. Volume 19. Issue 10. Oct 06, 2026. Epub Oct 06, 2026.

Abstract

A girl in the first decade of life presented with a 1.5 year history of gradually progressive bilateral upper eyelid swelling with bilateral proptosis, more prominent on the right side. She had a partial response to oral prednisolone, but symptoms recurred during tapering. Examination showed firm bilateral upper eyelid masses, preserved vision and mild restriction of upward gaze in the right eye. MRI demonstrated right preseptal/periorbital soft tissue thickening. Further evaluation excluded infection, vasculitis, sarcoidosis and malignancy; serum IgG4 level was normal. Biopsy of the right eyelid lesion showed concentric perivascular fibrosis with eosinophil-rich lymphoplasmacytic infiltrate, consistent with eosinophilic angiocentric fibrosis, supporting a diagnosis of possible organ-limited IgG4-related disease. The patient was treated with oral prednisolone and mycophenolate mofetil, resulting in sustained clinical improvement. This case highlights that paediatric IgG4-related disease may present as isolated orbital swelling with normal serum IgG4, making histopathology crucial for diagnosis.

PMID:
42838704
Bibliographic data and abstract were imported from PubMed on 07 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 2
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement